Terence J. Flood

Newcastle Upon Tyne, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

CD3+TCRαβ/CD19+-Depleted Mismatched Family or Unrelated Donor Salvage Stem Cell Transplantation for Graft Dysfunction in Inborn Errors of Immunity.

CD3+TCRαβ/CD19+-Depleted Mismatched Family or Unrelated Donor Salvage Stem Cell Transplantation for Graft Dysfunction in Inborn Errors of Immunity.

Journal: Transplantation and cellular therapy

Published: April 01, 2023

Haploidentical CD3+ TCR αβ/CD19+-depleted HSCT for MHC class II deficiency and persistent SARS-CoV-2 pneumonitis.

Haploidentical CD3+ TCR αβ/CD19+-depleted HSCT for MHC class II deficiency and persistent SARS-CoV-2 pneumonitis.

Journal: The journal of allergy and clinical immunology. Global

Published: May 29, 2022

TCRαβ-Depleted Haploidentical Grafts Are a Safe Alternative to HLA-Matched Unrelated Donor Stem Cell Transplants for Infants with Severe Combined Immunodeficiency.

TCRαβ-Depleted Haploidentical Grafts Are a Safe Alternative to HLA-Matched Unrelated Donor Stem Cell Transplants for Infants with Severe Combined Immunodeficiency.

Journal: Journal of clinical immunology

Published: September 02, 2021

Hematopoietic Cell Transplant for CD40 Ligand Deficiency-Comparing Busulfan Versus Treosulfan.

Hematopoietic Cell Transplant for CD40 Ligand Deficiency-Comparing Busulfan Versus Treosulfan.

Journal: Journal of clinical immunology

Published: August 19, 2021

Severe Combined Immunodeficiency (SCID)-the Irish Experience.

Severe Combined Immunodeficiency (SCID)-the Irish Experience.

Journal: Journal of clinical immunology

Published: April 10, 2021

Adenosine Deaminase Deficient SCID with Myocardial Hypertrophy.

Adenosine Deaminase Deficient SCID with Myocardial Hypertrophy.

Journal: Journal of clinical immunology

Published: January 07, 2021

New insights into risk factors for transplant-associated thrombotic microangiopathy in pediatric HSCT.

New insights into risk factors for transplant-associated thrombotic microangiopathy in pediatric HSCT.

Journal: Blood advances

Published: December 06, 2019

Proposed Therapeutic Range of Treosulfan in Reduced Toxicity Pediatric Allogeneic Hematopoietic Stem Cell Transplant Conditioning: Results From a Prospective Trial.

Proposed Therapeutic Range of Treosulfan in Reduced Toxicity Pediatric Allogeneic Hematopoietic Stem Cell Transplant Conditioning: Results From a Prospective Trial.

Journal: Clinical pharmacology and therapeutics

Published: August 07, 2019

Two decades of excellent transplant survival for chronic granulomatous disease: a supraregional immunology transplant center report.

Two decades of excellent transplant survival for chronic granulomatous disease: a supraregional immunology transplant center report.

Journal: Blood

Published: April 07, 2019

Hematopoietic Stem Cell Transplantation Resolves the Immune Deficit Associated with STAT3-Dominant-Negative Hyper-IgE Syndrome.

Hematopoietic Stem Cell Transplantation Resolves the Immune Deficit Associated with STAT3-Dominant-Negative Hyper-IgE Syndrome.

Journal: Journal of clinical immunology

Published: May 21, 2018

Allogeneic hematopoietic stem cell transplantation for severe, refractory juvenile idiopathic arthritis.

Allogeneic hematopoietic stem cell transplantation for severe, refractory juvenile idiopathic arthritis.

Journal: Blood advances

Published: November 22, 2017

Non-posttransplant lymphoproliferative disorder malignancy after hematopoietic stem cell transplantation in patients with primary immunodeficiency: UK experience.

Non-posttransplant lymphoproliferative disorder malignancy after hematopoietic stem cell transplantation in patients with primary immunodeficiency: UK experience.

Journal: The Journal of allergy and clinical immunology

Published: November 14, 2017

Showing 1-12 of 23

Last Updated: 09/26/2026